T1	Participants 97 204	patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors
T2	Participants 227 239	REFLEX study
T3	Participants 428 540	patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors
T4	Participants 550 568	Patients in REFLEX
T5	Participants 1243 1255	480 patients
